LTRN
Price
$3.98
Change
+$0.12 (+3.11%)
Updated
May 9 closing price
Capitalization
42.92M
XOMAO
Price
$25.04
Change
-$0.04 (-0.16%)
Updated
May 9 closing price
Capitalization
N/A
Ad is loading...

LTRN vs XOMAO

Header iconLTRN vs XOMAO Comparison
Open Charts LTRN vs XOMAOBanner chart's image
Lantern Pharma
Price$3.98
Change+$0.12 (+3.11%)
Volume$20.57K
Capitalization42.92M
XOMA
Price$25.04
Change-$0.04 (-0.16%)
Volume$1.85K
CapitalizationN/A
LTRN vs XOMAO Comparison Chart
Loading...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LTRN vs. XOMAO commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LTRN is a Hold and XOMAO is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (LTRN: $3.98 vs. XOMAO: $25.04)
Brand notoriety: LTRN and XOMAO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LTRN: 57% vs. XOMAO: 52%
Market capitalization -- LTRN: $42.92M vs. XOMAO: $0
LTRN [@Biotechnology] is valued at $42.92M. XOMAO’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LTRN’s FA Score shows that 1 FA rating(s) are green whileXOMAO’s FA Score has 1 green FA rating(s).

  • LTRN’s FA Score: 1 green, 4 red.
  • XOMAO’s FA Score: 1 green, 4 red.
According to our system of comparison, LTRN is a better buy in the long-term than XOMAO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LTRN’s TA Score shows that 6 TA indicator(s) are bullish.

  • LTRN’s TA Score: 6 bullish, 5 bearish.

Price Growth

LTRN (@Biotechnology) experienced а +12.43% price change this week, while XOMAO (@Biotechnology) price change was +0.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

LTRN is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LTRN YTD gains are higher at: 24.765 vs. XOMAO (1.709). XOMAO has higher annual earnings (EBITDA): -5.42M vs. LTRN (-21.18M). XOMAO has more cash in the bank: 93.3M vs. LTRN (28.1M). LTRN has less debt than XOMAO: LTRN (291K) vs XOMAO (119M). XOMAO has higher revenues than LTRN: XOMAO (10.2M) vs LTRN (0).
LTRNXOMAOLTRN / XOMAO
Capitalization42.9MN/A-
EBITDA-21.18M-5.42M391%
Gain YTD24.7651.7091,449%
P/E RatioN/AN/A-
Revenue010.2M-
Total Cash28.1M93.3M30%
Total Debt291K119M0%
TECHNICAL ANALYSIS
Technical Analysis
LTRN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 13 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Ad is loading...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VAL38.210.74
+1.97%
Valaris Limited
JOB0.18N/A
+1.85%
GEE Group
VLO122.931.20
+0.99%
Valero Energy Corp
CMTG2.43N/A
N/A
Claros Mortgage Trust
SMTI32.35-0.05
-0.15%
Sanara MedTech

LTRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with ABCL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
+3.11%
ABCL - LTRN
37%
Loosely correlated
+1.00%
ATAI - LTRN
37%
Loosely correlated
-0.71%
ABSI - LTRN
37%
Loosely correlated
-1.79%
RXRX - LTRN
36%
Loosely correlated
-1.37%
DNA - LTRN
36%
Loosely correlated
-1.40%
More

XOMAO and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMAO has been closely correlated with AMLX. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if XOMAO jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMAO
1D Price
Change %
XOMAO100%
-0.17%
AMLX - XOMAO
68%
Closely correlated
+0.66%
XOMAP - XOMAO
30%
Poorly correlated
-1.36%
ATAI - XOMAO
24%
Poorly correlated
-0.71%
LTRN - XOMAO
23%
Poorly correlated
+3.11%
KALV - XOMAO
23%
Poorly correlated
-2.38%
More